| Association of chemerin with oxidative stress, inflammation and classical adipokines in non‐diabetic obese patients P Fülöp, I Seres, H Lőrincz, M Harangi, S Somodi, G Paragh Journal of cellular and molecular medicine 18 (7), 1313-1320, 2014 | 90 | 2014 |
| High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus K Gaál, T Tarr, H Lőrincz, V Borbás, I Seres, M Harangi, P Fülöp, ... Lipids in health and disease 15, 1-8, 2016 | 65 | 2016 |
| Strong correlations between circulating chemerin levels and lipoprotein subfractions in nondiabetic obese and nonobese subjects H Lőrincz, M Katkó, M Harangi, S Somodi, K Gaál, P Fülöp, G Paragh, ... Clinical endocrinology 81 (3), 370-377, 2014 | 49 | 2014 |
| Plasminogen Activator Inhibitor‐1 Level Correlates with Lipoprotein Subfractions in Obese Nondiabetic Subjects S Somodi, I Seres, H Lőrincz, M Harangi, P Fülöp, G Paragh International Journal of Endocrinology 2018 (1), 9596054, 2018 | 35 | 2018 |
| HDL subfraction distribution and HDL function in untreated dyslipidemic patients M Harangi, A Szentpéteri, B Nádró, H Lőrincz, I Seres, D Páll, G Paragh undefined 1, 166-173, 2017 | 20 | 2017 |
| Effects of alpha-lipoic acid treatment on serum progranulin levels and inflammatory markers in diabetic neuropathy B Nádró, H Lőrincz, Á Molnár, A Szentpéteri, E Zöld, I Seres, D Páll, ... Journal of International Medical Research 49 (5), 03000605211012213, 2021 | 18 | 2021 |
| Paraoxonase-1 arylesterase activity is an independent predictor of myeloperoxidase levels in overweight patients with or without cardiovascular complications N Zsíros, P Koncsos, H Lőrincz, I Seres, M Katkó, A Szentpéteri, VE Varga, ... Clinical biochemistry 49 (12), 862-867, 2016 | 18 | 2016 |
| Serum obestatin level strongly correlates with lipoprotein subfractions in non-diabetic obese patients A Szentpéteri, H Lőrincz, S Somodi, VE Varga, G Paragh, I Seres, ... Lipids in Health and Disease 17, 1-8, 2018 | 16 | 2018 |
| Afamin levels and their correlation with oxidative and lipid parameters in non-diabetic, obese patients I Juhász, S Ujfalusi, I Seres, H Lőrincz, VE Varga, G Paragh Jr, S Somodi, ... Biomolecules 12 (1), 116, 2022 | 14 | 2022 |
| Crucial regulatory role of organokines in relation to metabolic changes in non-diabetic obesity H Lőrincz, S Somodi, B Ratku, M Harangi, G Paragh Metabolites 13 (2), 270, 2023 | 12 | 2023 |
| Clinical aspects of genetic and non-genetic cardiovascular risk factors in familial hypercholesterolemia E Berta, N Zsíros, M Bodor, I Balogh, H Lőrincz, G Paragh, M Harangi Genes 13 (7), 1158, 2022 | 12 | 2022 |
| Paraoxonase-1 and myeloperoxidase correlate with vascular biomarkers in overweight patients with newly diagnosed untreated hyperlipidaemia A Szentpéteri, N Zsíros, VE Varga, H Lőrincz, M Katkó, I Seres, P Fülöp, ... Vasa 46 (5), 370-376, 2017 | 11 | 2017 |
| Low Levels of Serum Fetuin-A and Retinol-Binding Protein 4 Correlate with Lipoprotein Subfractions in Morbid Obese and Lean Non-Diabetic Subjects H Lőrincz, I Csige, M Harangi, A Szentpéteri, I Seres, Z Szabó, G Paragh, ... Life 11 (9), 881, 2021 | 9 | 2021 |
| Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia VE Varga, H Lőrincz, N Zsíros, P Fülöp, I Seres, G Paragh, J Balla, ... Lipids in Health and Disease 15, 1-7, 2016 | 9 | 2016 |
| Determination of serum progranulin in patients with untreated familial hypercholesterolemia B Nádró, H Lőrincz, L Juhász, A Szentpéteri, F Sztanek, É Varga, D Páll, ... Biomedicines 10 (4), 771, 2022 | 7 | 2022 |
| Role of altered metabolism of triglyceride-rich lipoprotein particles in the development of vascular dysfunction in systemic lupus erythematosus Á Diószegi, H Lőrincz, E Kaáli, P Soltész, B Perge, É Varga, M Harangi, ... Biomolecules 13 (3), 401, 2023 | 6 | 2023 |
| Changes in serum afamin and vitamin E levels after selective LDL apheresis VE Varga, H Lőrincz, A Szentpéteri, L Juhász, I Seres, G Paragh Jr, ... Journal of clinical apheresis 33 (5), 569-575, 2018 | 6 | 2018 |
| Characterization of a novel high-density lipoprotein antioxidant capacity assay and its application to high-density lipoprotein fractions K Gaál, H Lőrincz, I Seres, M Harangi, AV Oláh, G Paragh Clinical Biochemistry 46 (9), 825-827, 2013 | 5 | 2013 |
| Sphingosine 1-phosphate and apolipoprotein M levels and their correlations with inflammatory biomarkers in patients with untreated familial hypercholesterolemia L Juhász, H Lőrincz, A Szentpéteri, B Nádró, É Varga, G Paragh, ... International Journal of Molecular Sciences 23 (22), 14065, 2022 | 4 | 2022 |
| Change of fibroblast growth factor 21 level correlates with the severity of diabetic sensory polyneuropathy after six-week physical activity Á Molnár, A Szentpéteri, H Lőrincz, I Seres, M Harangi, Z Balogh, ... Reviews in Cardiovascular Medicine 23 (5), 160, 2022 | 4 | 2022 |
